piracetam has been researched along with Pulmonary Eosinophilia in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a case of eosinophilic pneumonia due to levetiracetam use in a non-smoking woman aged 59 years with no previous respiratory history." | 1.46 | Levetiracetam-induced eosinophilic pneumonia. ( Fagan, A; Fuld, J; Soon, E, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fagan, A | 1 |
| Fuld, J | 1 |
| Soon, E | 1 |
1 other study available for piracetam and Pulmonary Eosinophilia
| Article | Year |
|---|---|
Levetiracetam-induced eosinophilic pneumonia.
Topics: Female; Humans; Levetiracetam; Middle Aged; Piracetam; Prednisolone; Pulmonary Eosinophilia; Treatme | 2017 |